NIH Pragmatic Trials Conducted in Health Care Systems

The NIH Pragmatic Trials Conducted in Health Care Systems opportunity is a forecasted federal funding initiative from the National Institutes of Health, within the U.S. Department of Health and Human Services. This program is designed to support large-scale pragmatic and implementation trials that are embedded directly within real-world health care settings. The initiative reflects NIH’s broader mission to advance biomedical and behavioral research that improves health outcomes, with a specific focus on generating evidence that is immediately relevant to patients, clinicians, administrators, policymakers, and payers. By prioritizing trials conducted in routine care environments, the program emphasizes practical applicability and generalizability of findings across diverse health systems. The primary purpose of this funding opportunity is to evaluate the effectiveness of interventions under typical clinical conditions and to test strategies for implementing these interventions across health care settings. Supported projects may include pragmatic trials that compare benefits, risks, and burdens of interventions, as well as implementation trials that assess how best to integrate evidence-based practices into clinical workflows. The program encourages applicants to select care environments where the target condition is commonly treated, such as primary care clinics, emergency departments, or public health settings, and to incorporate multiple types of health systems to enhance the external validity of results. Funding will support a phased cooperative agreement structure, meaning that awards will include both a planning phase and a full-scale execution phase. During the planning phase, awardees are expected to refine study design, establish partnerships, and prepare for implementation. Progression to the execution phase is contingent upon meeting predefined milestones. The cooperative agreement mechanism indicates substantial involvement from NIH program staff, particularly in monitoring progress and ensuring adherence to milestones. While specific funding amounts, award ceilings, and total program funding have not yet been announced, the scale of trials suggests substantial investment per award. Eligibility for this opportunity is broad and inclusive, encompassing a wide range of organizational types. Eligible applicants include nonprofit organizations, for-profit entities, small businesses, institutions of higher education, state and local governments, tribal governments, and other organizations such as faith-based and community-based entities. Both U.S.-based and non-U.S. institutions may be eligible, and federal agencies are also included among potential applicants. This inclusive approach reflects the need for diverse expertise and collaboration across sectors to successfully conduct large-scale health system trials. The application process has not yet opened, as this is a forecasted opportunity intended to provide advance notice. The estimated application due date is February 23, 2027, with an anticipated posting date in late November 2026. Applicants are encouraged to begin early planning, including forming collaborations and developing study concepts aligned with program priorities. The funding opportunity does not require cost sharing or matching funds, lowering barriers to participation. Contact with NIH program staff is available via email, providing a channel for prospective applicants to seek guidance as they prepare for submission. Evaluation criteria are expected to focus on scientific rigor, feasibility, relevance to real-world clinical practice, and the potential to inform decision-making in health care systems. Emphasis will likely be placed on the ability to conduct trials across diverse settings, integrate interventions into routine care, and produce findings that can be generalized broadly. The estimated award date and project start date are both December 1, 2027, indicating a structured timeline from application submission through project initiation. As a forecasted opportunity, this program is not yet accepting applications, but it represents a significant upcoming funding pathway for organizations engaged in health systems research.

Design proposals that demonstrate real-world applicability across multiple health systems and clearly address implementation feasibility and generalizability